Population
American population (general public for polio vaccination)
Design
Guideline
Authors
Loading...
Enables U.S. licensing and commercial supply of live oral polio vaccine by 1961; extends international conference data into national manufacturing standards.
The 1960 Surgeon General statement established the regulatory and manufacturing framework for introducing the live oral poliovirus vaccine in the United States.
Leroy E. Burney (1960) studied Poliomyelitis. Live oral poliovirus vaccine (Sabin strains) was evaluated. The Public Health Service Committee recommended the use of Sabin type 1 and type 2 strains for live oral poliovirus vaccine manufacture due to their favorable laboratory and field characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: